{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:22:16Z","timestamp":1777674136147,"version":"3.51.4"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12022-022-09707-3","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T21:02:20Z","timestamp":1647291740000},"page":"27-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":981,"title":["Overview of the 2022 WHO Classification of Thyroid Neoplasms"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-3069","authenticated-orcid":false,"given":"Zubair W.","family":"Baloch","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7167-4358","authenticated-orcid":false,"given":"Justine A.","family":"Barletta","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9835","authenticated-orcid":false,"given":"Ronald A.","family":"Ghossein","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-9081","authenticated-orcid":false,"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-3708","authenticated-orcid":false,"given":"Chan Kwon","family":"Jung","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7035-5259","authenticated-orcid":false,"given":"Virginia A.","family":"LiVolsi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-1700","authenticated-orcid":false,"given":"Mauro G.","family":"Papotti","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-1235","authenticated-orcid":false,"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-6682","authenticated-orcid":false,"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"9707_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1034\/j.1399-0004.2001.600203.x","volume":"60","author":"AE Chudley","year":"2001","unstructured":"Chudley AE. History of genetics through philately--Carl Linnaeus (Carl von Linne). Clin Genet 2001; 60:104-106","journal-title":"Clin Genet"},{"key":"9707_CR2","first-page":"4","volume":"73","author":"CT Ambrose","year":"2010","unstructured":"Ambrose CT. Carolus Linnaeus (Carl von Linne), 1707-1778: the Swede who named almost everything. Pharos Alpha Omega Alpha Honor Med Soc 2010; 73:4-10","journal-title":"Pharos Alpha Omega Alpha Honor Med Soc"},{"key":"9707_CR3","unstructured":"WHO Classification of Tumours of Endocrine Organs. Vol 10. 4th ed. Lyon, France: WHO\/IARC Press."},{"key":"9707_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/er.2004-0005","volume":"26","author":"K Krohn","year":"2005","unstructured":"Krohn K, Fuhrer D, Bayer Y, et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 2005; 26:504-524","journal-title":"Endocr Rev"},{"key":"9707_CR5","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1210\/jc.2002-021552","volume":"88","author":"L Jovanovic","year":"2003","unstructured":"Jovanovic L, Delahunt B, McIver B, et al. Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab 2003; 88:3284-3291","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1043-2760(01)00519-7","volume":"13","author":"M Derwahl","year":"2002","unstructured":"Derwahl M, Studer H. Hyperplasia versus adenoma in endocrine tissues: are they different? Trends Endocrinol Metab 2002; 13:23-28","journal-title":"Trends Endocrinol Metab"},{"key":"9707_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s004230050159","volume":"383","author":"P Harrer","year":"1998","unstructured":"Harrer P, Brocker M, Zint A, et al. The clonality of nodules in recurrent goiters at second surgery. Langenbecks Arch Surg 1998; 383:453-455","journal-title":"Langenbecks Arch Surg"},{"key":"9707_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00019606-199506000-00007","volume":"4","author":"RL Apel","year":"1995","unstructured":"Apel RL, Ezzat S, Bapat BV, et al. Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 1995; 4:113-121","journal-title":"Diagn Mol Pathol"},{"key":"9707_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2018.10.001","volume":"48","author":"SL Asa","year":"2019","unstructured":"Asa SL. The Current Histologic Classification of Thyroid Cancer. Endocrinol Metab Clin North Am 2019; 48:1-22","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9707_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1530\/eje.1.02253","volume":"155","author":"HI Gozu","year":"2006","unstructured":"Gozu HI, Bircan R, Krohn K, et al. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 2006; 155:535-545","journal-title":"Eur J Endocrinol"},{"key":"9707_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s001090000170","volume":"78","author":"B Trulzsch","year":"2001","unstructured":"Trulzsch B, Krohn K, Wonerow P, et al. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med (Berl) 2001; 78:684-691","journal-title":"J Mol Med (Berl)"},{"key":"9707_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/365649a0","volume":"365","author":"J Parma","year":"1993","unstructured":"Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365:649-651","journal-title":"Nature"},{"key":"9707_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12022-020-09638-x","volume":"31","author":"JM Cameselle-Teijeiro","year":"2020","unstructured":"Cameselle-Teijeiro JM, Eloy C, Sobrinho-Simoes M. Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers. Endocr Pathol 2020; 31:197-217","journal-title":"Endocr Pathol"},{"key":"9707_CR14","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1172\/JCI84894","volume":"126","author":"D Calebiro","year":"2016","unstructured":"Calebiro D, Grassi ES, Eszlinger M, et al. Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas. J Clin Invest 2016; 126:3383-3388","journal-title":"J Clin Invest"},{"key":"9707_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s001090050141","volume":"75","author":"A Porcellini","year":"1997","unstructured":"Porcellini A, Fenzi G, Avvedimento EV. Mutations of thyrotropin receptor gene. J Mol Med (Berl) 1997; 75:567-575","journal-title":"J Mol Med (Berl)"},{"key":"9707_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/a-0753-4943","volume":"127","author":"CDC Kamilaris","year":"2019","unstructured":"Kamilaris CDC, Faucz FR, Voutetakis A, et al. Carney Complex. Exp Clin Endocrinol Diabetes 2019; 127:156-164","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"9707_CR17","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1158\/0008-5472.CAN-06-0171","volume":"66","author":"E Bonora","year":"2006","unstructured":"Bonora E, Porcelli AM, Gasparre G, et al. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Research 2006; 66:6087-6096","journal-title":"Cancer Research"},{"key":"9707_CR18","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1073\/pnas.0703056104","volume":"104","author":"G Gasparre","year":"2007","unstructured":"Gasparre G, Porcelli AM, Bonora E, et al. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A 2007; 104:9001-9006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9707_CR19","doi-asserted-by":"crossref","unstructured":"Gopal RK, K\u00fcbler K, Calvo SE, et al. Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma. Cancer Cell 2018; 34:242\u2013255. e245","DOI":"10.1016\/j.ccell.2018.06.013"},{"key":"9707_CR20","doi-asserted-by":"crossref","unstructured":"Ganly I, Makarov V, Deraje S, et al. Integrated genomic analysis of H\u00fcrthle Cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell 2018; 34:256\u2013270. e255","DOI":"10.1016\/j.ccell.2018.07.002"},{"key":"9707_CR21","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/sj.bjc.6602547","volume":"92","author":"V Maximo","year":"2005","unstructured":"Maximo V, Botelho T, Capela J, et al. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 2005; 92:1892-1898","journal-title":"Br J Cancer"},{"key":"9707_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/ERC-20-0435","volume":"28","author":"WR Doerfler","year":"2021","unstructured":"Doerfler WR, Nikitski AV, Morariu EM, et al. Molecular alterations in Hurthle cell nodules and preoperative cancer risk. Endocr Relat Cancer 2021; 28:301-309","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/modpathol.2017.9","volume":"30","author":"U Cho","year":"2017","unstructured":"Cho U, Mete O, Kim MH, et al. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol 2017; 30:810-825","journal-title":"Mod Pathol"},{"key":"9707_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/his.13401","volume":"72","author":"TH Kim","year":"2018","unstructured":"Kim TH, Lee M, Kwon AY, et al. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Histopathology 2018; 72:648-661","journal-title":"Histopathology"},{"key":"9707_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00268-017-4182-5","volume":"42","author":"DN Parente","year":"2018","unstructured":"Parente DN, Kluijfhout WP, Bongers PJ, et al. Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign? World J Surg 2018; 42:321-326","journal-title":"World J Surg"},{"key":"9707_CR26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/jamaoncol.2018.1446","volume":"4","author":"YE Nikiforov","year":"2018","unstructured":"Nikiforov YE, Baloch ZW, Hodak SP, et al. Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features. JAMA Oncol 2018; 4:1125-1126","journal-title":"JAMA Oncol"},{"key":"9707_CR27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","volume":"2","author":"YE Nikiforov","year":"2016","unstructured":"Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol 2016; 2:1023-1029","journal-title":"JAMA Oncol"},{"key":"9707_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12020-019-01848-6","volume":"64","author":"B Xu","year":"2019","unstructured":"Xu B, Reznik E, Tuttle RM, et al. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features. Endocrine 2019; 64:97-108","journal-title":"Endocrine"},{"key":"9707_CR29","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1089\/thy.2019.0328","volume":"29","author":"B Xu","year":"2019","unstructured":"Xu B, Serrette R, Tuttle RM, et al. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid 2019; 29:1792-1803","journal-title":"Thyroid"},{"key":"9707_CR30","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1089\/thy.2016.0649","volume":"27","author":"B Xu","year":"2017","unstructured":"Xu B, Tallini G, Scognamiglio T, et al. Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid 2017; 27:512-517","journal-title":"Thyroid"},{"key":"9707_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1530\/ERC-16-0379","volume":"23","author":"PW Rosario","year":"2016","unstructured":"Rosario PW, Mourao GF, Nunes MB, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Endocr Relat Cancer 2016; 23:893-897","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12020-017-1484-1","volume":"59","author":"B Xu","year":"2018","unstructured":"Xu B, Farhat N, Barletta JA, et al. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category? Endocrine 2018; 59:143-150","journal-title":"Endocrine"},{"key":"9707_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/modpathol.2016.65","volume":"29","author":"LD Thompson","year":"2016","unstructured":"Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol 2016; 29:698-707","journal-title":"Mod Pathol"},{"key":"9707_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/modpathol.2017.130","volume":"31","author":"RR Seethala","year":"2018","unstructured":"Seethala RR, Baloch ZW, Barletta JA, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol 2018; 31:39-55","journal-title":"Mod Pathol"},{"key":"9707_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00428-009-0798-7","volume":"455","author":"V Hofman","year":"2009","unstructured":"Hofman V, Lassalle S, Bonnetaud C, et al. Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch 2009; 455:21-33","journal-title":"Virchows Arch"},{"key":"9707_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13000-019-0817-1","volume":"14","author":"H Duan","year":"2019","unstructured":"Duan H, Liu X, Ren X, et al. Mutation profiles of follicular thyroid tumors by targeted sequencing. Diagn Pathol 2019; 14:39","journal-title":"Diagn Pathol"},{"key":"9707_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/PAS.0000000000001489","volume":"44","author":"V Cracolici","year":"2020","unstructured":"Cracolici V, Ritterhouse LL, Segal JP, et al. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas. Am J Surg Pathol 2020; 44:881-892","journal-title":"Am J Surg Pathol"},{"key":"9707_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1066896918809490","volume":"27","author":"CC Juhlin","year":"2019","unstructured":"Juhlin CC, Branstrom R, Shabo I, et al. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report. Int J Surg Pathol 2019; 27:290-293","journal-title":"Int J Surg Pathol"},{"key":"9707_CR39","first-page":"1686025","volume":"2021","author":"D Cabibi","year":"2021","unstructured":"Cabibi D, Mondello A, Florena AM, et al. A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration. Case Rep Pathol 2021; 2021:1686025","journal-title":"Case Rep Pathol"},{"key":"9707_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12022-009-9103-1","volume":"21","author":"J Rosai","year":"2010","unstructured":"Rosai J. The encapsulated follicular variant of papillary thyroid carcinoma: back to the drawing board. Endocr Pathol 2010; 21:7-11","journal-title":"Endocr Pathol"},{"key":"9707_CR41","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/thy.2016.0547","volume":"27","author":"SE Lee","year":"2017","unstructured":"Lee SE, Hwang TS, Choi YL, et al. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF(V600E) Mutation. Thyroid 2017; 27:802-810","journal-title":"Thyroid"},{"key":"9707_CR42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12022-018-9519-6","volume":"29","author":"A Bychkov","year":"2018","unstructured":"Bychkov A, Jung CK, Liu Z, et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology. Endocr Pathol 2018; 29:276-288","journal-title":"Endocr Pathol"},{"key":"9707_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12022-016-9437-4","volume":"27","author":"H Baser","year":"2016","unstructured":"Baser H, Topaloglu O, Tam AA, et al. Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas. Endocr Pathol 2016; 27:233-242","journal-title":"Endocr Pathol"},{"key":"9707_CR44","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1097\/PAS.0b013e31817a8f1b","volume":"32","author":"JA Carney","year":"2008","unstructured":"Carney JA, Hirokawa M, Lloyd RV, et al. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol 2008; 32:1877-1889","journal-title":"Am J Surg Pathol"},{"key":"9707_CR45","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/00000478-200012000-00004","volume":"24","author":"M Papotti","year":"2000","unstructured":"Papotti M, Volante M, Giuliano A, et al. RET\/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 2000; 24:1615-1621","journal-title":"Am J Surg Pathol"},{"key":"9707_CR46","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1097\/00000478-200012000-00005","volume":"24","author":"CC Cheung","year":"2000","unstructured":"Cheung CC, Boerner SL, MacMillan CM, et al. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 2000; 24:1622-1626","journal-title":"Am J Surg Pathol"},{"key":"9707_CR47","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ejca.2005.01.004","volume":"41","author":"G Salvatore","year":"2005","unstructured":"Salvatore G, Chiappetta G, Nikiforov YE, et al. Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET\/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 2005; 41:816-821","journal-title":"Eur J Cancer"},{"key":"9707_CR48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1365-2559.2010.03526.x","volume":"56","author":"SY Sheu","year":"2010","unstructured":"Sheu SY, Vogel E, Worm K, et al. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 2010; 56:632-640","journal-title":"Histopathology"},{"key":"9707_CR49","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/s41379-019-0313-x","volume":"32","author":"C Marchio","year":"2019","unstructured":"Marchio C, Da Cruz Paula A, Gularte-Merida R, et al. PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid. Mod Pathol 2019; 32:1734-1743","journal-title":"Mod Pathol"},{"key":"9707_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/thy.2018.0791","volume":"29","author":"MN Nikiforova","year":"2019","unstructured":"Nikiforova MN, Nikitski AV, Panebianco F, et al. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland. Thyroid 2019; 29:161-173","journal-title":"Thyroid"},{"key":"9707_CR51","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cncy.22163","volume":"127","author":"MN Nikiforova","year":"2019","unstructured":"Nikiforova MN, Nikiforov YE, Ohori NP. GLIS rearrangements in thyroid nodules: A key to preoperative diagnosis of hyalinizing trabecular tumor. Cancer Cytopathol 2019; 127:560-566","journal-title":"Cancer Cytopathol"},{"key":"9707_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0046-8177(94)90277-1","volume":"25","author":"K Molberg","year":"1994","unstructured":"Molberg K, Albores-Saavedra J. Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol 1994; 25:192-197","journal-title":"Hum Pathol"},{"key":"9707_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2559.1996.d01-432.x","volume":"28","author":"WG McCluggage","year":"1996","unstructured":"McCluggage WG, Sloan JM. Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 1996; 28:357-362","journal-title":"Histopathology"},{"key":"9707_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02915330","volume":"2","author":"C Sambade","year":"1991","unstructured":"Sambade C, Franssila K, Cameselle-Teijeiro J, et al. Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland. Endocr Pathol 1991; 2:83-91","journal-title":"Endocr Pathol"},{"key":"9707_CR55","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1097\/01.pas.0000135519.34847.f6","volume":"28","author":"RV Lloyd","year":"2004","unstructured":"Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004; 28:1336-1340","journal-title":"Am J Surg Pathol"},{"key":"9707_CR56","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1309\/AJCPKP2QUVN4RCCP","volume":"130","author":"TM Elsheikh","year":"2008","unstructured":"Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 2008; 130:736-744","journal-title":"Am J Clin Pathol"},{"key":"9707_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00428-003-0962-4","volume":"444","author":"M Papotti","year":"2004","unstructured":"Papotti M, Manazza AD, Chiarle R, et al. Confocal microscope analysis and tridimensional reconstruction of papillary thyroid carcinoma nuclei. Virchows Arch 2004; 444:350-355","journal-title":"Virchows Arch"},{"key":"9707_CR58","doi-asserted-by":"crossref","unstructured":"Asa SL, Mete O. Oncocytic Change in Thyroid Pathology. Front Endocrinol (Lausanne) 2021; 12:678119","DOI":"10.3389\/fendo.2021.678119"},{"key":"9707_CR59","doi-asserted-by":"crossref","unstructured":"Lukovic J, Petrovic I, Liu Z, et al. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome. Front Endocrinol (Lausanne) 2021; 12:795184","DOI":"10.3389\/fendo.2021.795184"},{"key":"9707_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejso.2010.11.005","volume":"37","author":"CJ O\u2019Neill","year":"2011","unstructured":"O\u2019Neill CJ, Vaughan L, Learoyd DL, et al. Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 2011; 37:181-185","journal-title":"Eur J Surg Oncol"},{"key":"9707_CR61","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.humpath.2015.08.015","volume":"46","author":"B Xu","year":"2015","unstructured":"Xu B, Wang L, Tuttle RM, et al. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases. Hum Pathol 2015; 46:1789-1798","journal-title":"Hum Pathol"},{"key":"9707_CR62","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41574-020-00414-9","volume":"16","author":"CM Kitahara","year":"2020","unstructured":"Kitahara CM, Sosa JA. Understanding the ever-changing incidence of thyroid cancer. Nat Rev Endocrinol 2020; 16:617-618","journal-title":"Nat Rev Endocrinol"},{"key":"9707_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/his.13373","volume":"72","author":"J Guilmette","year":"2018","unstructured":"Guilmette J, Nose V. Hereditary and familial thyroid tumours. Histopathology 2018; 72:70-81","journal-title":"Histopathology"},{"key":"9707_CR64","doi-asserted-by":"crossref","unstructured":"Vickery AL, Jr. Thyroid papillary carcinoma. Pathological and philosophical controversies. Am J Surg Pathol 1983; 7:797\u2013807.","DOI":"10.1097\/00000478-198307080-00009"},{"key":"9707_CR65","doi-asserted-by":"crossref","unstructured":"Carcangiu M, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 244 cases treated at the University of Florence, Italy. Cancer 1985; 55:805\u2013828","DOI":"10.1002\/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO;2-Z"},{"key":"9707_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1210\/jc.2016-2976","volume":"102","author":"G Tallini","year":"2017","unstructured":"Tallini G, Tuttle RM, Ghossein RA. The History of the Follicular Variant of Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 2017; 102:15-22","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26:1-133","journal-title":"Thyroid"},{"key":"9707_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70:7-30","journal-title":"CA Cancer J Clin"},{"key":"9707_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.surg.2019.03.040","volume":"167","author":"B Saravana-Bawan","year":"2020","unstructured":"Saravana-Bawan B, Bajwa A, Paterson J, et al. Active surveillance of low-risk papillary thyroid cancer: A meta-analysis. Surgery 2020; 167:46-55","journal-title":"Surgery"},{"key":"9707_CR70","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/thy.2008.0210","volume":"19","author":"A Rego-Iraeta","year":"2009","unstructured":"Rego-Iraeta A, Perez-Mendez LF, Mantinan B, et al. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 2009; 19:333-340","journal-title":"Thyroid"},{"key":"9707_CR71","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1089\/thy.2019.0159","volume":"29","author":"SJ Cho","year":"2019","unstructured":"Cho SJ, Suh CH, Baek JH, et al. Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis. Thyroid 2019; 29:1399-1408","journal-title":"Thyroid"},{"key":"9707_CR72","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1089\/thy.2016.0100","volume":"26","author":"JJ Wiltshire","year":"2016","unstructured":"Wiltshire JJ, Drake TM, Uttley L, et al. Systematic Review of Trends in the Incidence Rates of Thyroid Cancer. Thyroid 2016; 26:1541-1552","journal-title":"Thyroid"},{"key":"9707_CR73","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159:676\u2013690","DOI":"10.1016\/j.cell.2014.09.050"},{"key":"9707_CR74","doi-asserted-by":"crossref","unstructured":"Nylen C, Mechera R, Marechal-Ross I, et al. Molecular Markers Guiding Thyroid Cancer Management. Cancers (Basel) 2020; 12","DOI":"10.3390\/cancers12082164"},{"key":"9707_CR75","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1530\/EC-17-0010","volume":"6","author":"HG Vuong","year":"2017","unstructured":"Vuong HG, Duong UN, Altibi AM, et al. A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocr Connect 2017; 6:R8-R17","journal-title":"Endocr Connect"},{"key":"9707_CR76","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.18632\/oncotarget.12885","volume":"8","author":"HG Vuong","year":"2017","unstructured":"Vuong HG, Altibi AM, Abdelhamid AH, et al. The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review. Oncotarget 2017; 8:10637-10649","journal-title":"Oncotarget"},{"key":"9707_CR77","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000456576","volume":"150","author":"GC Penna","year":"2016","unstructured":"Penna GC, Vaisman F, Vaisman M, et al. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes. Cytogenet Genome Res 2016; 150:194-207","journal-title":"Cytogenet Genome Res"},{"key":"9707_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2014.0540","volume":"25","author":"SL Asa","year":"2015","unstructured":"Asa SL, Giordano TJ, LiVolsi VA. Implications of the TCGA genomic characterization of papillary thyroid carcinoma for thyroid pathology: does follicular variant papillary thyroid carcinoma exist? Thyroid 2015; 25:1-2","journal-title":"Thyroid"},{"key":"9707_CR79","doi-asserted-by":"crossref","unstructured":"Vuong HG, Altibi AMA, Duong UNP, et al. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma - a meta-analysis. Clin Endocrinol (Oxf) 2017;","DOI":"10.1111\/cen.13413"},{"key":"9707_CR80","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/thy.2016.0350","volume":"27","author":"S Moon","year":"2017","unstructured":"Moon S, Song YS, Kim YA, et al. Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis. Thyroid 2017; 27:651-660","journal-title":"Thyroid"},{"key":"9707_CR81","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/cncr.27893","volume":"119","author":"RJ Leeman-Neill","year":"2013","unstructured":"Leeman-Neill RJ, Brenner AV, Little MP, et al. RET\/PTC and PAX8\/PPARgamma chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer 2013; 119:1792-1799","journal-title":"Cancer"},{"key":"9707_CR82","doi-asserted-by":"crossref","unstructured":"Yoo SK, Lee S, Kim SJ, et al. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers. PLoS Genet 2016; 12:e1006239","DOI":"10.1371\/journal.pgen.1006239"},{"key":"9707_CR83","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu YH, Dias-Santagata D, Farahani AA, et al. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Mod Pathol 2020; 33:2186-2197","journal-title":"Mod Pathol"},{"key":"9707_CR84","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/dc.24190","volume":"47","author":"JW Sistrunk","year":"2019","unstructured":"Sistrunk JW, Shifrin A, Frager M, et al. Clinical impact of testing for mutations and microRNAs in thyroid nodules. Diagn Cytopathol 2019; 47:758-764","journal-title":"Diagn Cytopathol"},{"key":"9707_CR85","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/cen.13928","volume":"90","author":"K Pak","year":"2019","unstructured":"Pak K, Suh S, Goh TS, et al. BRAF-positive multifocal and unifocal papillary thyroid cancer show different messenger RNA expressions. Clin Endocrinol (Oxf) 2019; 90:601-607","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9707_CR86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.pap.0000213006.10362.17","volume":"13","author":"ZW Baloch","year":"2006","unstructured":"Baloch ZW, LiVolsi VA. Microcarcinoma of the thyroid. Adv Anat Pathol 2006; 13:69-75","journal-title":"Adv Anat Pathol"},{"key":"9707_CR87","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ctrv.2005.04.009","volume":"31","author":"GH Sakorafas","year":"2005","unstructured":"Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 2005; 31:423-438","journal-title":"Cancer Treat Rev"},{"key":"9707_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2019.00010","volume":"10","author":"F Yang","year":"2019","unstructured":"Yang F, Zhong Q, Huang Z, et al. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC\/UICC Staging System Based on the SEER Database. Front Endocrinol (Lausanne) 2019; 10:10","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9707_CR89","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.2147\/CMAR.S169741","volume":"10","author":"WX Jin","year":"2018","unstructured":"Jin WX, Ye DR, Sun YH, et al. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag Res 2018; 10:3237-3243","journal-title":"Cancer Manag Res"},{"key":"9707_CR90","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/thy.2008.0185","volume":"19","author":"N Arora","year":"2009","unstructured":"Arora N, Turbendian HK, Kato MA, et al. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 2009; 19:473-477","journal-title":"Thyroid"},{"key":"9707_CR91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hed.21142","volume":"32","author":"YJ Park","year":"2010","unstructured":"Park YJ, Kim YA, Lee YJ, et al. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck 2010; 32:38-45","journal-title":"Head Neck"},{"key":"9707_CR92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/thy.2012.0645","volume":"24","author":"R Ghossein","year":"2014","unstructured":"Ghossein R, Ganly I, Biagini A, et al. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases. Thyroid 2014; 24:245-253","journal-title":"Thyroid"},{"key":"9707_CR93","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.humpath.2012.06.019","volume":"44","author":"S Piana","year":"2013","unstructured":"Piana S, Ragazzi M, Tallini G, et al. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol 2013; 44:556-565","journal-title":"Hum Pathol"},{"key":"9707_CR94","doi-asserted-by":"crossref","unstructured":"Pitoia F, Jerkovich F, Urciuoli C, et al. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence. Thyroid 2015;","DOI":"10.1089\/thy.2015.0121"},{"key":"9707_CR95","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mpdhp.2019.02.001","volume":"25","author":"K Shafique","year":"2019","unstructured":"Shafique K, Baloch Z. Risk stratification of papillary thyroid carcinoma and its variants; from clinicopathologic features to molecular profiling. Diagnostic Histopathology 2019; 25:143-153","journal-title":"Diagnostic Histopathology"},{"key":"9707_CR96","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4158\/EP-2018-0130","volume":"24","author":"CL Twining","year":"2018","unstructured":"Twining CL, Lupo MA, Tuttle RM. Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules\/Differentiated Thyroid Cancer Guidelines Across Practice Types. Endocr Pract 2018; 24:833-840","journal-title":"Endocr Pract"},{"issue":"Pt 1","key":"9707_CR97","first-page":"1","volume":"20","author":"ML Carcangiu","year":"1985","unstructured":"Carcangiu ML, Zampi G, Rosai J. Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathology annual 1985; 20 Pt 1:1-44","journal-title":"Pathology annual"},{"key":"9707_CR98","doi-asserted-by":"publisher","first-page":"e4072","DOI":"10.1210\/clinem\/dgab396","volume":"106","author":"C Giani","year":"2021","unstructured":"Giani C, Torregrossa L, Ramone T, et al. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer. J Clin Endocrinol Metab 2021; 106:e4072-e4083","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR99","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12022-020-09650-1","volume":"32","author":"D Akbulut","year":"2021","unstructured":"Akbulut D, Kuz ED, Kursun N, et al. Capsular Invasion Matters Also in \u201cPapillary Patterned\u201d Tumors: A Study on 121 Cases of Encapsulated Conventional Variant of Papillary Thyroid Carcinoma. Endocr Pathol 2021; 32:357-367","journal-title":"Endocr Pathol"},{"key":"9707_CR100","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/1097-0142(19840701)54:1<90::AID-CNCR2820540119>3.0.CO;2-0","volume":"54","author":"S Schroder","year":"1984","unstructured":"Schroder S, Bocker W, Dralle H, et al. The encapsulated papillary carcinoma of the thyroid: A morphologic subtype of the papillary thyroid carcinoma. Cancer 1984; 54:90","journal-title":"Cancer"},{"key":"9707_CR101","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/thy.2008.0303","volume":"19","author":"M Rivera","year":"2009","unstructured":"Rivera M, Tuttle RM, Patel S, et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 2009; 19:119-127","journal-title":"Thyroid"},{"key":"9707_CR102","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/jclinpath-2013-201626","volume":"66","author":"Z Baloch","year":"2013","unstructured":"Baloch Z, LiVolsi VA, Tondon R. Aggressive variants of follicular cell derived thyroid carcinoma; the so called \u2018real thyroid carcinomas\u2019. J Clin Pathol 2013; 66:733-743","journal-title":"J Clin Pathol"},{"key":"9707_CR103","doi-asserted-by":"crossref","unstructured":"Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010; 34:44\u201352","DOI":"10.1097\/PAS.0b013e3181c46677"},{"key":"9707_CR104","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/PAP.0000000000000184","volume":"25","author":"MC Nath","year":"2018","unstructured":"Nath MC, Erickson LA. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid. Adv Anat Pathol 2018; 25:172-179","journal-title":"Adv Anat Pathol"},{"key":"9707_CR105","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ejso.2017.09.019","volume":"44","author":"N Janjua","year":"2018","unstructured":"Janjua N, Wreesmann VB. Aggressive differentiated thyroid cancer. Eur J Surg Oncol 2018; 44:367-377","journal-title":"Eur J Surg Oncol"},{"key":"9707_CR106","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1245\/s10434-011-2129-x","volume":"19","author":"HS Kazaure","year":"2012","unstructured":"Kazaure HS, Roman SA, Sosa JA. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. Annals of surgical oncology 2012; 19:1874-1880","journal-title":"Annals of surgical oncology"},{"key":"9707_CR107","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/hed.21494","volume":"33","author":"CE Silver","year":"2011","unstructured":"Silver CE, Owen RP, Rodrigo JP, et al. Aggressive variants of papillary thyroid carcinoma. Head Neck 2011; 33:1052-1059","journal-title":"Head Neck"},{"key":"9707_CR108","doi-asserted-by":"crossref","unstructured":"Evans HL. Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis. Am J Surg Pathol 1996; 20:1205\u20131211","DOI":"10.1097\/00000478-199610000-00005"},{"key":"9707_CR109","doi-asserted-by":"crossref","unstructured":"Agarwal S, Sadiq Q, Ortanca I. Hobnail cells in encapsulated papillary thyroid carcinoma: Report of 2 cases with immunohistochemical and molecular findings and literature analysis. Pathol Res Pract 2020; 216:152678","DOI":"10.1016\/j.prp.2019.152678"},{"key":"9707_CR110","doi-asserted-by":"publisher","first-page":"40792","DOI":"10.18632\/oncotarget.8215","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Cheng W, Liu C, et al. Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology. Oncotarget 2016; 7:40792-40799","journal-title":"Oncotarget"},{"key":"9707_CR111","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1089\/thy.2012.0455","volume":"23","author":"V Sujoy","year":"2013","unstructured":"Sujoy V, Pinto A, Nose V. Columnar cell variant of papillary thyroid carcinoma: a study of 10 cases with emphasis on CDX2 expression. Thyroid 2013; 23:714-719","journal-title":"Thyroid"},{"key":"9707_CR112","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s40618-020-01456-6","volume":"44","author":"MM Moura","year":"2021","unstructured":"Moura MM, Cabrera RA, Esteves S, et al. Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma. J Endocrinol Invest 2021; 44:1837-1846","journal-title":"J Endocrinol Invest"},{"key":"9707_CR113","doi-asserted-by":"crossref","unstructured":"Macerola E, Poma AM, Vignali P, et al. Molecular Genetics of Follicular-Derived Thyroid Cancer. Cancers (Basel) 2021; 13","DOI":"10.3390\/cancers13051139"},{"key":"9707_CR114","doi-asserted-by":"crossref","unstructured":"Macerola E, Proietti A, Poma AM, et al. Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution. Cancers (Basel) 2021; 13","DOI":"10.3390\/cancers13133123"},{"key":"9707_CR115","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-16-0863","volume":"176","author":"HG Vuong","year":"2017","unstructured":"Vuong HG, Kondo T, Pham TQ, et al. Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol 2017; 176:431-439","journal-title":"Eur J Endocrinol"},{"key":"9707_CR116","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.critrevonc.2014.12.001","volume":"94","author":"S Pillai","year":"2015","unstructured":"Pillai S, Gopalan V, Smith RA, et al. Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology. Crit Rev Oncol Hematol 2015; 94:64-73","journal-title":"Crit Rev Oncol Hematol"},{"key":"9707_CR117","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.3892\/ol.2017.5948","volume":"13","author":"R Villar-Taibo","year":"2017","unstructured":"Villar-Taibo R, Peteiro-Gonzalez D, Cabezas-Agricola JM, et al. Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age. Oncol Lett 2017; 13:3501-3507","journal-title":"Oncol Lett"},{"key":"9707_CR118","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1007\/s00259-019-04456-8","volume":"46","author":"V Wenter","year":"2019","unstructured":"Wenter V, Jellinek A, Unterrainer M, et al. Long-term outcome of rare oncocytic papillary (H\u00fcrthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy. European journal of nuclear medicine and molecular imaging 2019; 46:2526-2535","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"9707_CR119","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0046-8177(97)90278-1","volume":"28","author":"M Berho","year":"1997","unstructured":"Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 1997; 28:47-53.","journal-title":"Hum Pathol"},{"key":"9707_CR120","doi-asserted-by":"crossref","unstructured":"Apel RL, Asa SL, LiVolsi VA. Papillary Hurthle cell carcinoma with lymphocytic stroma. \u201cWarthin-like tumor\u201d of the thyroid. Am J Surg Pathol 1995; 19:810\u2013814.","DOI":"10.1097\/00000478-199507000-00009"},{"key":"9707_CR121","doi-asserted-by":"crossref","unstructured":"Yeo MK, Bae JS, Lee S, et al. The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto\u2019s Thyroiditis. Int J Endocrinol 2015; 2015:456027","DOI":"10.1155\/2015\/456027"},{"key":"9707_CR122","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/01.pas.0000213417.00386.74","volume":"31","author":"J Albores-Saavedra","year":"2007","unstructured":"Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, et al. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions. Am J Surg Pathol 2007; 31:729-736","journal-title":"Am J Surg Pathol"},{"key":"9707_CR123","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/modpathol.2016.173","volume":"30","author":"C Rebecchini","year":"2017","unstructured":"Rebecchini C, Nobile A, Piana S, et al. Papillary thyroid carcinoma with nodular fasciitis-like stroma and beta-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis. Mod Pathol 2017; 30:236-245","journal-title":"Mod Pathol"},{"key":"9707_CR124","first-page":"366","volume":"8","author":"Y Mizukami","year":"1995","unstructured":"Mizukami Y, Kurumaya H, Kitagawa T, et al. Papillary carcinoma of the thyroid gland with fibromatosis-like stroma: a case report and review of the literature. Mod Pathol 1995; 8:366-370.","journal-title":"Mod Pathol"},{"key":"9707_CR125","doi-asserted-by":"crossref","unstructured":"Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol 2011; 22:190\u2013194","DOI":"10.1007\/s12022-011-9176-5"},{"key":"9707_CR126","doi-asserted-by":"crossref","unstructured":"Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983; 52:1849\u20131855","DOI":"10.1002\/1097-0142(19831115)52:10<1849::AID-CNCR2820521015>3.0.CO;2-X"},{"key":"9707_CR127","doi-asserted-by":"crossref","unstructured":"Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (\u201cinsular\u201d) thyroid carcinoma. A reinterpretation of Langhans\u2019 \u201cwuchernde Struma\u201d. Am J Surg Pathol 1984; 8:655\u2013668","DOI":"10.1097\/00000478-198409000-00005"},{"key":"9707_CR128","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1385\/EP:15:4:293","volume":"15","author":"J Rosai","year":"2004","unstructured":"Rosai J. Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 2004; 15:293-296","journal-title":"Endocr Pathol"},{"key":"9707_CR129","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007; 31:1256-1264","journal-title":"Am J Surg Pathol"},{"key":"9707_CR130","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1902::AID-CNCR20>3.0.CO;2-Y","volume":"88","author":"LA Akslen","year":"2000","unstructured":"Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 2000; 88:1902-1908","journal-title":"Cancer"},{"key":"9707_CR131","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/cncr.21739","volume":"106","author":"D Hiltzik","year":"2006","unstructured":"Hiltzik D, Carlson DL, Tuttle RM, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 2006; 106:1286-1295","journal-title":"Cancer"},{"key":"9707_CR132","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/thy.2020.0668","volume":"31","author":"KS Wong","year":"2021","unstructured":"Wong KS, Dong F, Telatar M, et al. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid 2021; 31:933-940","journal-title":"Thyroid"},{"key":"9707_CR133","doi-asserted-by":"crossref","unstructured":"Xu B, David J, Dogan S, et al. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology 2021;","DOI":"10.1111\/his.14550"},{"key":"9707_CR134","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/cncr.23515","volume":"113","author":"M Rivera","year":"2008","unstructured":"Rivera M, Ghossein RA, Schoder H, et al. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 2008; 113:48-56","journal-title":"Cancer"},{"key":"9707_CR135","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","volume":"32","author":"M Volante","year":"2021","unstructured":"Volante M, Lam AK, Papotti M, et al. Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? Endocr Pathol 2021; 32:63-76","journal-title":"Endocr Pathol"},{"key":"9707_CR136","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/jc.2013-3842","volume":"99","author":"T Ibrahimpasic","year":"2014","unstructured":"Ibrahimpasic T, Ghossein R, Carlson DL, et al. Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 2014; 99:1245-1252","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR137","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/cncr.20087","volume":"100","author":"M Volante","year":"2004","unstructured":"Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 2004; 100:950-957","journal-title":"Cancer"},{"key":"9707_CR138","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1365-2559.2012.04188.x","volume":"60","author":"M Dettmer","year":"2012","unstructured":"Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome. Histopathology 2012; 60:1045-1051","journal-title":"Histopathology"},{"key":"9707_CR139","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12022-015-9367-6","volume":"26","author":"S Bai","year":"2015","unstructured":"Bai S, Baloch ZW, Samulski TD, et al. Poorly differentiated oncocytic (hurthle cell) follicular carcinoma: an institutional experience. Endocr Pathol 2015; 26:164-169","journal-title":"Endocr Pathol"},{"key":"9707_CR140","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/thy.2016.0631","volume":"27","author":"NA Cipriani","year":"2017","unstructured":"Cipriani NA, Agarwal S, Dias-Santagata D, et al. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies. Thyroid 2017; 27:819-824","journal-title":"Thyroid"},{"key":"9707_CR141","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41379-021-00825-7","volume":"34","author":"IA Cree","year":"2021","unstructured":"Cree IA, Tan PH, Travis WD, et al. Counting mitoses: SI(ze) matters! Mod Pathol 2021; 34:1651-1657","journal-title":"Mod Pathol"},{"key":"9707_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.EJ14-0293","volume":"62","author":"K Kakudo","year":"2015","unstructured":"Kakudo K, Wakasa T, Ohta Y, et al. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas. Endocr J 2015; 62:1-12","journal-title":"Endocr J"},{"key":"9707_CR143","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/s41379-020-0532-1","volume":"33","author":"B Alzumaili","year":"2020","unstructured":"Alzumaili B, Xu B, Spanheimer PM, et al. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome. Mod Pathol 2020; 33:1690-1701","journal-title":"Mod Pathol"},{"key":"9707_CR144","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/PAS.0000000000001505","volume":"44","author":"TL Fuchs","year":"2020","unstructured":"Fuchs TL, Nassour AJ, Glover A, et al. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis. Am J Surg Pathol 2020; 44:1419-1428","journal-title":"Am J Surg Pathol"},{"key":"9707_CR145","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.21.01329","volume":"40","author":"B Xu","year":"2022","unstructured":"Xu B, Fuchs TL, Ahmadi S, et al. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. J Clin Oncol 2022; 40:96-104","journal-title":"J Clin Oncol"},{"key":"9707_CR146","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest 2016; 126:1052-1066","journal-title":"J Clin Invest"},{"key":"9707_CR147","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/modpathol.2010.117","volume":"23","author":"S Asioli","year":"2010","unstructured":"Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 2010; 23:1269-1278","journal-title":"Mod Pathol"},{"key":"9707_CR148","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.humpath.2009.08.011","volume":"41","author":"M Rivera","year":"2010","unstructured":"Rivera M, Ricarte-Filho J, Patel S, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate\/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 2010; 41:172-180","journal-title":"Hum Pathol"},{"key":"9707_CR149","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41379-020-0458-7","volume":"33","author":"RD Chernock","year":"2020","unstructured":"Chernock RD, Rivera B, Borrelli N, et al. Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol 2020; 33:1264-1274","journal-title":"Mod Pathol"},{"key":"9707_CR150","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","volume":"30","author":"B Xu","year":"2020","unstructured":"Xu B, Fuchs T, Dogan S, et al. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases. Thyroid 2020; 30:1505-1517","journal-title":"Thyroid"},{"key":"9707_CR151","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2559.2001.01207.x","volume":"39","author":"KY Lam","year":"2001","unstructured":"Lam KY, Lo CY, Liu MC. Primary squamous cell carcinoma of the thyroid gland: an entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles. Histopathology 2001; 39:279-286","journal-title":"Histopathology"},{"key":"9707_CR152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13044-020-00091-w","volume":"13","author":"S De Leo","year":"2020","unstructured":"De Leo S, Trevisan M, Fugazzola L. Recent advances in the management of anaplastic thyroid cancer. Thyroid Res 2020; 13:17","journal-title":"Thyroid Res"},{"key":"9707_CR153","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.semdp.2020.03.004","volume":"37","author":"JB Jalaly","year":"2020","unstructured":"Jalaly JB, Baloch ZW. Hurthle-cell neoplasms of the thyroid: An algorithmic approach to pathologic diagnosis in light of molecular advances. Semin Diagn Pathol 2020; 37:234-242","journal-title":"Semin Diagn Pathol"},{"key":"9707_CR154","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/cncr.27770","volume":"119","author":"P Goffredo","year":"2013","unstructured":"Goffredo P, Roman SA, Sosa JA. Hurthle cell carcinoma: a population-level analysis of 3311 patients. Cancer 2013; 119:504-511","journal-title":"Cancer"},{"key":"9707_CR155","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1097\/00005537-200212000-00009","volume":"112","author":"LD Dahl","year":"2002","unstructured":"Dahl LD, Myssiorek D, Heller KS. Hurthle cell neoplasms of the thyroid. Laryngoscope 2002; 112:2178-2180","journal-title":"Laryngoscope"},{"key":"9707_CR156","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1245\/s10434-013-2965-y","volume":"20","author":"K Sugino","year":"2013","unstructured":"Sugino K, Kameyama K, Ito K, et al. Does Hurthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma? Annals of surgical oncology 2013; 20:2944-2950","journal-title":"Annals of surgical oncology"},{"key":"9707_CR157","doi-asserted-by":"crossref","unstructured":"Haigh PI, Urbach DR. The treatment and prognosis of Hurthle cell follicular thyroid carcinoma compared with its non-Hurthle cell counterpart. Surgery 2005; 138:1152\u20131157; discussion 1157\u20131158","DOI":"10.1016\/j.surg.2005.08.034"},{"key":"9707_CR158","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1089\/thy.2011.0407","volume":"22","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, Wu G, Tufano RP, et al. Histological patterns of locoregional recurrence in Hurthle cell carcinoma of the thyroid gland. Thyroid 2012; 22:690-694","journal-title":"Thyroid"},{"key":"9707_CR159","doi-asserted-by":"crossref","unstructured":"Kure S, Ohashi R. Thyroid Hurthle Cell Carcinoma: Clinical, Pathological, and Molecular Features. Cancers (Basel) 2020; 13","DOI":"10.3390\/cancers13010026"},{"key":"9707_CR160","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1210\/jc.2014-1634","volume":"100","author":"AM Chindris","year":"2015","unstructured":"Chindris AM, Casler JD, Bernet VJ, et al. Clinical and molecular features of Hurthle cell carcinoma of the thyroid. J Clin Endocrinol Metab 2015; 100:55-62","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR161","doi-asserted-by":"crossref","unstructured":"Ganly I, Makarov V, Deraje S, et al. Integrated Genomic Analysis of Hurthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. Cancer Cell 2018; 34:256\u2013270 e255","DOI":"10.1016\/j.ccell.2018.07.002"},{"key":"9707_CR162","unstructured":"Gopal RK, Kubler K, Calvo SE, et al. Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hurthle Cell Carcinoma. Cancer Cell 2018; 34:242\u2013255 e245"},{"key":"9707_CR163","doi-asserted-by":"publisher","first-page":"E962","DOI":"10.1210\/jc.2012-3539","volume":"98","author":"I Ganly","year":"2013","unstructured":"Ganly I, Ricarte Filho J, Eng S, et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab 2013; 98:E962-972","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR164","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4158\/EP-2020-0101","volume":"26","author":"CW Wong","year":"2020","unstructured":"Wong CW, Schumm MA, Zhu CY, et al. Quality of Life Following Molecular Marker Testing for Indeterminate Thyroid Nodules. Endocr Pract 2020; 26:960-966","journal-title":"Endocr Pract"},{"key":"9707_CR165","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/cncy.22217","volume":"128","author":"C Bellevicine","year":"2020","unstructured":"Bellevicine C, Migliatico I, Sgariglia R, et al. Evaluation of BRAF, RAS, RET\/PTC, and PAX8\/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy. Cancer Cytopathol 2020; 128:107-118","journal-title":"Cancer Cytopathol"},{"key":"9707_CR166","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cncy.22112","volume":"127","author":"YE Nikiforov","year":"2019","unstructured":"Nikiforov YE, Baloch ZW. Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology. Cancer Cytopathol 2019; 127:225-230","journal-title":"Cancer Cytopathol"},{"key":"9707_CR167","doi-asserted-by":"crossref","unstructured":"Pisapia P, Pepe F, Iaccarino A, et al. BRAF: A Two-Faced Janus. Cells 2020; 9","DOI":"10.3390\/cells9122549"},{"key":"9707_CR168","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.21037\/gs-20-430","volume":"9","author":"FA Rashid","year":"2020","unstructured":"Rashid FA, Munkhdelger J, Fukuoka J, et al. Prevalence of BRAF(V600E) mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review. Gland Surg 2020; 9:1878-1900","journal-title":"Gland Surg"},{"key":"9707_CR169","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","volume":"32","author":"M Xing","year":"2014","unstructured":"Xing M, Liu R, Liu X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 2014; 32:2718-2726","journal-title":"J Clin Oncol"},{"key":"9707_CR170","doi-asserted-by":"publisher","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","volume":"99","author":"X Liu","year":"2014","unstructured":"Liu X, Qu S, Liu R, et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab 2014; 99:E1130-1136","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR171","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1038\/onc.2013.446","volume":"33","author":"T Liu","year":"2014","unstructured":"Liu T, Wang N, Cao J, et al. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene 2014; 33:4978-4984","journal-title":"Oncogene"},{"key":"9707_CR172","doi-asserted-by":"publisher","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","volume":"98","author":"I Landa","year":"2013","unstructured":"Landa I, Ganly I, Chan TA, et al. Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab 2013; 98:E1562-1566","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR173","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1089\/thy.2019.0459","volume":"30","author":"CK Jung","year":"2020","unstructured":"Jung CK, Jung SH, Jeon S, et al. Risk Stratification Using a Novel Genetic Classifier Including PLEKHS1 Promoter Mutations for Differentiated Thyroid Cancer with Distant Metastasis. Thyroid 2020; 30:1589-1600","journal-title":"Thyroid"},{"key":"9707_CR174","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2013-3734","volume":"99","author":"M Melo","year":"2014","unstructured":"Melo M, da Rocha AG, Vinagre J, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 2014; 99:E754-765","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR175","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/ERC-13-0210","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu X, Bishop J, Shan Y, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 2013; 20:603-610","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR176","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/gcc.22928","volume":"60","author":"BA McKelvey","year":"2021","unstructured":"McKelvey BA, Zeiger MA, Umbricht CB. Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study. Genes Chromosomes Cancer 2021; 60:403-409","journal-title":"Genes Chromosomes Cancer"},{"key":"9707_CR177","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1089\/thy.2018.0695","volume":"29","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Matsuse M, Saenko V, et al. TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas. Thyroid 2019; 29:1105-1114","journal-title":"Thyroid"},{"key":"9707_CR178","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1530\/ERC-18-0050","volume":"25","author":"JO Paulsson","year":"2018","unstructured":"Paulsson JO, Mu N, Shabo I, et al. TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. Endocr Relat Cancer 2018; 25:723-733","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR179","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41574-021-00470-9","volume":"17","author":"D Salvatore","year":"2021","unstructured":"Salvatore D, Santoro M, Schlumberger M. The importance of the RET gene in thyroid cancer and therapeutic implications. Nat Rev Endocrinol 2021; 17:296-306","journal-title":"Nat Rev Endocrinol"},{"key":"9707_CR180","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1210\/jc.2004-1811","volume":"90","author":"CM Caudill","year":"2005","unstructured":"Caudill CM, Zhu Z, Ciampi R, et al. Dose-dependent generation of RET\/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. J Clin Endocrinol Metab 2005; 90:2364-2369","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR181","doi-asserted-by":"crossref","unstructured":"Pekova B, Sykorova V, Mastnikova K, et al. NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis. Cancers (Basel) 2021; 13","DOI":"10.3390\/cancers13081932"},{"key":"9707_CR182","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1089\/thy.2020.0589","volume":"31","author":"EM Morariu","year":"2021","unstructured":"Morariu EM, McCoy KL, Chiosea SI, et al. Clinicopathologic Characteristics of Thyroid Nodules Positive for the THADA-IGF2BP3 Fusion on Preoperative Molecular Analysis. Thyroid 2021; 31:1212-1218","journal-title":"Thyroid"},{"key":"9707_CR183","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12022-020-09648-9","volume":"31","author":"YC Lee","year":"2020","unstructured":"Lee YC, Chen JY, Huang CJ, et al. Detection of NTRK1\/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing. Endocr Pathol 2020; 31:348-358","journal-title":"Endocr Pathol"},{"key":"9707_CR184","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1089\/thy.2019.0802","volume":"30","author":"B Pekova","year":"2020","unstructured":"Pekova B, Sykorova V, Dvorakova S, et al. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid 2020; 30:1771-1780","journal-title":"Thyroid"},{"key":"9707_CR185","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1530\/ERC-19-0325","volume":"26","author":"F Panebianco","year":"2019","unstructured":"Panebianco F, Nikitski AV, Nikiforova MN, et al. Characterization of thyroid cancer driven by known and novel ALK fusions. Endocr Relat Cancer 2019; 26:803-814","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR186","doi-asserted-by":"crossref","unstructured":"Xing X, Mu N, Yuan X, et al. PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma. Cancers (Basel) 2020; 12","DOI":"10.3390\/cancers12082133"},{"key":"9707_CR187","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","volume":"23","author":"T Ibrahimpasic","year":"2017","unstructured":"Ibrahimpasic T, Xu B, Landa I, et al. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clin Cancer Res 2017; 23:5970-5980","journal-title":"Clin Cancer Res"},{"key":"9707_CR188","doi-asserted-by":"publisher","first-page":"R415","DOI":"10.1530\/ERC-19-0093","volume":"26","author":"C Zafon","year":"2019","unstructured":"Zafon C, Gil J, Perez-Gonzalez B, et al. DNA methylation in thyroid cancer. Endocr Relat Cancer 2019; 26:R415-R439","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR189","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1210\/jc.2017-01613","volume":"103","author":"EN Klein Hesselink","year":"2018","unstructured":"Klein Hesselink EN, Zafon C, Villalmanzo N, et al. Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer. J Clin Endocrinol Metab 2018; 103:397-406","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR190","doi-asserted-by":"crossref","unstructured":"Rogucki M, Buczynska A, Kretowski AJ, et al. The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer. J Clin Med 2021; 10","DOI":"10.3390\/jcm10204738"},{"key":"9707_CR191","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA, Jr. Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med 2016; 375:1054-1067","journal-title":"N Engl J Med"},{"key":"9707_CR192","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrendo.2014.115","volume":"10","author":"P Raman","year":"2014","unstructured":"Raman P, Koenig RJ. Pax-8-PPAR-gamma fusion protein in thyroid carcinoma. Nat Rev Endocrinol 2014; 10:616-623","journal-title":"Nat Rev Endocrinol"},{"key":"9707_CR193","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jc.2002-021907","volume":"88","author":"MN Nikiforova","year":"2003","unstructured":"Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003; 88:2318-2326","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR194","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0002-9440(10)63902-8","volume":"162","author":"CA French","year":"2003","unstructured":"French CA, Alexander EK, Cibas ES, et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol 2003; 162:1053-1060","journal-title":"Am J Pathol"},{"key":"9707_CR195","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1210\/jc.2006-2019","volume":"92","author":"Y Wang","year":"2007","unstructured":"Wang Y, Hou P, Yu H, et al. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase\/akt pathway in thyroid tumors. J Clin Endocrinol Metab 2007; 92:2387-2390","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR196","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-06-1125","volume":"13","author":"P Hou","year":"2007","unstructured":"Hou P, Liu D, Shan Y, et al. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase\/Akt pathway in thyroid cancer. Clin Cancer Res 2007; 13:1161-1170","journal-title":"Clin Cancer Res"},{"key":"9707_CR197","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12022-021-09688-9","volume":"32","author":"JS Bae","year":"2021","unstructured":"Bae JS, Jung SH, Hirokawa M, et al. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Endocr Pathol 2021; 32:336-346","journal-title":"Endocr Pathol"},{"key":"9707_CR198","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1210\/clinem\/dgab471","volume":"106","author":"JO Paulsson","year":"2021","unstructured":"Paulsson JO, Rafati N, DiLorenzo S, et al. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8. J Clin Endocrinol Metab 2021; 106:3265-3282","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR199","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1210\/jc.2018-00277","volume":"103","author":"NG Nicolson","year":"2018","unstructured":"Nicolson NG, Murtha TD, Dong W, et al. Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology. J Clin Endocrinol Metab 2018; 103:2640-2650","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR200","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/his.14416","volume":"79","author":"CC Juhlin","year":"2021","unstructured":"Juhlin CC, Stenman A, Zedenius J. Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features. Histopathology 2021; 79:661-666","journal-title":"Histopathology"},{"key":"9707_CR201","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/cncy.22329","volume":"128","author":"A Darbinyan","year":"2020","unstructured":"Darbinyan A, Morotti R, Cai G, et al. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients. Cancer Cytopathol 2020; 128:746-756","journal-title":"Cancer Cytopathol"},{"key":"9707_CR202","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/thy.2018.0607","volume":"30","author":"M Bongiovanni","year":"2020","unstructured":"Bongiovanni M, Sykiotis GP, La Rosa S, et al. Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma. Thyroid 2020; 30:72-80","journal-title":"Thyroid"},{"key":"9707_CR203","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12022-021-09695-w","volume":"32","author":"JO Paulsson","year":"2021","unstructured":"Paulsson JO, Zedenius J, Juhlin CC. TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression. Endocr Pathol 2021; 32:513-516","journal-title":"Endocr Pathol"},{"key":"9707_CR204","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/PAS.0000000000001208","volume":"43","author":"V Cracolici","year":"2019","unstructured":"Cracolici V, Kadri S, Ritterhouse LL, et al. Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis. Am J Surg Pathol 2019; 43:514-522","journal-title":"Am J Surg Pathol"},{"key":"9707_CR205","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1530\/ERC-16-0219","volume":"23","author":"TH Kim","year":"2016","unstructured":"Kim TH, Kim YE, Ahn S, et al. TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocr Relat Cancer 2016; 23:813-823","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR206","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/thy.2015.0527","volume":"26","author":"SY Sohn","year":"2016","unstructured":"Sohn SY, Park WY, Shin HT, et al. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer. Thyroid 2016; 26:672-682","journal-title":"Thyroid"},{"key":"9707_CR207","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12022-009-9102-2","volume":"21","author":"O Mete","year":"2010","unstructured":"Mete O, Asa SL. Oncocytes, oxyphils, Hurthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol 2010; 21:16-24","journal-title":"Endocr Pathol"},{"key":"9707_CR208","doi-asserted-by":"crossref","unstructured":"Corver WE, Ruano D, Weijers K, et al. Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma. PLoS One 2012; 7:e38287","DOI":"10.1371\/journal.pone.0038287"},{"key":"9707_CR209","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1053\/hupa.2000.8444","volume":"31","author":"L Mazzucchelli","year":"2000","unstructured":"Mazzucchelli L, Burckhardt E, Hirsiger H, et al. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland. Hum Pathol 2000; 31:854-859","journal-title":"Hum Pathol"},{"key":"9707_CR210","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/00000478-200107000-00009","volume":"25","author":"LA Erickson","year":"2001","unstructured":"Erickson LA, Jalal SM, Goellner JR, et al. Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. Am J Surg Pathol 2001; 25:911-917","journal-title":"Am J Surg Pathol"},{"key":"9707_CR211","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.5359","volume":"250","author":"JO Paulsson","year":"2020","unstructured":"Paulsson JO, Backman S, Wang N, et al. Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation. J Pathol 2020; 250:183-194","journal-title":"J Pathol"},{"key":"9707_CR212","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/thy.2019.0263","volume":"29","author":"KS Wong","year":"2019","unstructured":"Wong KS, Lorch JH, Alexander EK, et al. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid 2019; 29:1255-1261","journal-title":"Thyroid"},{"key":"9707_CR213","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1530\/EC-18-0386","volume":"7","author":"D de Biase","year":"2018","unstructured":"de Biase D, Torricelli F, Ragazzi M, et al. Not the same thing: metastatic PTCs have a different background than ATCs. Endocr Connect 2018; 7:1370-1379","journal-title":"Endocr Connect"},{"key":"9707_CR214","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"N Pozdeyev","year":"2018","unstructured":"Pozdeyev N, Gay LM, Sokol ES, et al. Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers. Clin Cancer Res 2018; 24:3059-3068","journal-title":"Clin Cancer Res"},{"key":"9707_CR215","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/hmg\/ddu749","volume":"24","author":"JW Kunstman","year":"2015","unstructured":"Kunstman JW, Juhlin CC, Goh G, et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum Mol Genet 2015; 24:2318-2329","journal-title":"Hum Mol Genet"},{"key":"9707_CR216","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1089\/thy.2018.0716","volume":"29","author":"KS Wong","year":"2019","unstructured":"Wong KS, Lorch JH, Alexander EK, et al. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas. Thyroid 2019; 29:666-673","journal-title":"Thyroid"},{"key":"9707_CR217","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12022-019-09585-2","volume":"30","author":"R Singarayer","year":"2019","unstructured":"Singarayer R, Mete O, Perrier L, et al. A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology. Endocr Pathol 2019; 30:201-218","journal-title":"Endocr Pathol"},{"key":"9707_CR218","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.humpath.2016.02.008","volume":"53","author":"N Oishi","year":"2016","unstructured":"Oishi N, Kondo T, Vuong HG, et al. Immunohistochemical detection of NRAS(Q61R) protein in follicular-patterned thyroid tumors. Hum Pathol 2016; 53:51-57","journal-title":"Hum Pathol"},{"key":"9707_CR219","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/ERC-14-0467","volume":"22","author":"G Park","year":"2015","unstructured":"Park G, Kim TH, Lee HO, et al. Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer. Endocr Relat Cancer 2015; 22:55-63","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR220","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.humpath.2020.09.004","volume":"106","author":"Y Nozaki","year":"2020","unstructured":"Nozaki Y, Yamamoto H, Iwasaki T, et al. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas. Hum Pathol 2020; 106:82-92","journal-title":"Hum Pathol"},{"key":"9707_CR221","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12022-020-09661-y","volume":"32","author":"JM Cameselle-Teijeiro","year":"2021","unstructured":"Cameselle-Teijeiro JM, Mete O, Asa SL, et al. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates. Endocr Pathol 2021; 32:77-101","journal-title":"Endocr Pathol"},{"key":"9707_CR222","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/PAS.0b013e31822fbc7d","volume":"35","author":"JA Barletta","year":"2011","unstructured":"Barletta JA, Bellizzi AM, Hornick JL. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome. Am J Surg Pathol 2011; 35:1505-1511","journal-title":"Am J Surg Pathol"},{"key":"9707_CR223","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12022-020-09652-z","volume":"31","author":"N Oishi","year":"2020","unstructured":"Oishi N, Vuong HG, Mochizuki K, et al. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations. Endocr Pathol 2020; 31:359-366","journal-title":"Endocr Pathol"},{"key":"9707_CR224","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12022-018-9551-6","volume":"29","author":"JO Paulsson","year":"2018","unstructured":"Paulsson JO, Olander A, Haglund F, et al. TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma. Endocr Pathol 2018; 29:380-383","journal-title":"Endocr Pathol"},{"key":"9707_CR225","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1210\/jcem-19-1-152","volume":"19","author":"JB Hazard","year":"1959","unstructured":"Hazard JB, Hawk WA, Crile G, Jr. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab 1959; 19:152-161","journal-title":"J Clin Endocrinol Metab"},{"key":"9707_CR226","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/his.14370","volume":"79","author":"F Najdawi","year":"2021","unstructured":"Najdawi F, Ahmadi S, Capelletti M, et al. Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas. Histopathology 2021; 79:427-436","journal-title":"Histopathology"},{"key":"9707_CR227","doi-asserted-by":"crossref","unstructured":"Saliba M, Mohanty AS, Ho AL, et al. Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic Features. Head Neck Pathol 2021;","DOI":"10.1007\/s12105-021-01386-6"},{"key":"9707_CR228","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12105-020-01193-5","volume":"15","author":"M Chambers","year":"2021","unstructured":"Chambers M, Nose V, Sadow PM, et al. Salivary-Like Tumors of the Thyroid: A Comprehensive Review of Three Rare Carcinomas. Head Neck Pathol 2021; 15:212-224","journal-title":"Head Neck Pathol"},{"key":"9707_CR229","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2147\/OTT.S158975","volume":"11","author":"J Wang","year":"2018","unstructured":"Wang J, Guli QR, Ming XC, et al. Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature. Onco Targets Ther 2018; 11:1521-1528","journal-title":"Onco Targets Ther"},{"key":"9707_CR230","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12022-013-9267-6","volume":"24","author":"NA Farhat","year":"2013","unstructured":"Farhat NA, Faquin WC, Sadow PM. Primary mucoepidermoid carcinoma of the thyroid gland: a report of three cases and review of the literature. Endocr Pathol 2013; 24:229-233","journal-title":"Endocr Pathol"},{"key":"9707_CR231","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/0046-8177(95)90272-4","volume":"26","author":"BM Wenig","year":"1995","unstructured":"Wenig BM, Adair CF, Heffess CS. Primary mucoepidermoid carcinoma of the thyroid gland: a report of six cases and a review of the literature of a follicular epithelial-derived tumor. Hum Pathol 1995; 26:1099-1108.","journal-title":"Hum Pathol"},{"key":"9707_CR232","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/modpathol.3880140","volume":"13","author":"ZW Baloch","year":"2000","unstructured":"Baloch ZW, Solomon AC, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Mod Pathol 2000; 13:802-807","journal-title":"Mod Pathol"},{"key":"9707_CR233","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000326372","volume":"44","author":"F Vazquez Ramirez","year":"2000","unstructured":"Vazquez Ramirez F, Otal Salaverri C, Argueta Manzano O, et al. Fine needle aspiration cytology of high grade mucoepidermoid carcinoma of the thyroid. A case report. Acta Cytol 2000; 44:259-264","journal-title":"A case report. Acta Cytol"},{"key":"9707_CR234","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2559.1984.tb02400.x","volume":"8","author":"KO Franssila","year":"1984","unstructured":"Franssila KO, Harach HR, Wasenius VM. Mucoepidermoid carcinoma of the thyroid. Histopathology 1984; 8:847-860","journal-title":"Histopathology"},{"key":"9707_CR235","doi-asserted-by":"publisher","first-page":"169","DOI":"10.12701\/yujm.2021.00941","volume":"38","author":"HC Shin","year":"2021","unstructured":"Shin HC. High-grade mucoepidermoid carcinoma in the thyroid gland with poor prognosis. Yeungnam Univ J Med 2021; 38:169-174","journal-title":"Yeungnam Univ J Med"},{"key":"9707_CR236","doi-asserted-by":"crossref","unstructured":"Lee K, Mirza O, Dobbs S, et al. Poorly differentiated mucoepidermoid carcinoma of the thyroid. BMJ Case Rep 2020; 13","DOI":"10.1136\/bcr-2020-236539"},{"key":"9707_CR237","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/his.13268","volume":"71","author":"EY Wu","year":"2017","unstructured":"Wu EY, Lebastchi J, Marqusee E, et al. A case of primary secretory carcinoma of the thyroid with high-grade features. Histopathology 2017; 71:665-669","journal-title":"Histopathology"},{"key":"9707_CR238","doi-asserted-by":"crossref","unstructured":"Huang NS, Cao YM, Lu ZW, et al. Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion. Oral Oncol 2021; 115:105092","DOI":"10.1016\/j.oraloncology.2020.105092"},{"key":"9707_CR239","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/modpathol.2016.115","volume":"29","author":"S Dogan","year":"2016","unstructured":"Dogan S, Wang L, Ptashkin RN, et al. Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Mod Pathol 2016; 29:985-995","journal-title":"Mod Pathol"},{"key":"9707_CR240","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/PAS.0000000000001535","volume":"44","author":"A Skalova","year":"2020","unstructured":"Skalova A, Baneckova M, Thompson LDR, et al. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion. Am J Surg Pathol 2020; 44:1295-1307","journal-title":"Am J Surg Pathol"},{"key":"9707_CR241","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s12105-018-0995-2","volume":"13","author":"MA Desai","year":"2019","unstructured":"Desai MA, Mehrad M, Ely KA, et al. Secretory Carcinoma of the Thyroid Gland: Report of a Highly Aggressive Case Clinically Mimicking Undifferentiated Carcinoma and Review of the Literature. Head Neck Pathol 2019; 13:562-572","journal-title":"Head Neck Pathol"},{"key":"9707_CR242","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000346705","volume":"57","author":"M Taweevisit","year":"2013","unstructured":"Taweevisit M, Sampatanukul P, Thorner PS. Ectopic thymoma can mimic benign and malignant thyroid lesions on fine needle aspiration cytology: a case report and literature review. Acta Cytol 2013; 57:213-220","journal-title":"Acta Cytol"},{"key":"9707_CR243","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/0377-4929.64294","volume":"53","author":"A Thakur","year":"2010","unstructured":"Thakur A, Sebag F, Micco CD, et al. Ectopic cervical thymoma mimicking as papillary thyroid carcinoma: a diagnostic dilemma. Indian J Pathol Microbiol 2010; 53:305-307","journal-title":"Indian J Pathol Microbiol"},{"key":"9707_CR244","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/dc.20258","volume":"32","author":"R Gerhard","year":"2005","unstructured":"Gerhard R, Kanashiro EH, Kliemann CM, et al. Fine-needle aspiration biopsy of ectopic cervical spindle-cell thymoma: a case report. Diagn Cytopathol 2005; 32:358-362","journal-title":"Diagn Cytopathol"},{"key":"9707_CR245","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/dc.24148","volume":"47","author":"AB Wiles","year":"2019","unstructured":"Wiles AB, Kraft AO, Mueller SM, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: Case report of a rare lesion with novel genetic mutation. Diagn Cytopathol 2019; 47:589-593","journal-title":"Diagn Cytopathol"},{"key":"9707_CR246","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3892\/ol.2015.3423","volume":"10","author":"YY Lee","year":"2015","unstructured":"Lee YY, Wang WC, Li CF. Aspiration cytology of an ectopic cervical thymoma misinterpreted as a lymphoproliferative lesion of the thyroid: A case report. Oncol Lett 2015; 10:1255-1258","journal-title":"Oncol Lett"},{"key":"9707_CR247","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4143\/crt.2013.184","volume":"47","author":"JM Noh","year":"2015","unstructured":"Noh JM, Ha SY, Ahn YC, et al. Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck. Cancer Res Treat 2015; 47:436-440","journal-title":"Cancer Res Treat"},{"key":"9707_CR248","doi-asserted-by":"crossref","unstructured":"Manukyan I, DeBrito P, Rossi CT, et al. Spindle epithelial tumor with thymus-like differentiation in fine needle aspiration of thyroid gland: Report of two cases. Diagn Cytopathol 2021;","DOI":"10.1002\/dc.24886"},{"key":"9707_CR249","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1159\/000514271","volume":"14","author":"E Kimura","year":"2021","unstructured":"Kimura E, Enomoto K, Kono M, et al. A Rare Case of Thyroid Carcinoma Showing Thymus-Like Differentiation in a Young Adult. Case Rep Oncol 2021; 14:671-675","journal-title":"Case Rep Oncol"},{"key":"9707_CR250","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1308\/rcsann.2019.0116","volume":"102","author":"S Karaisli","year":"2020","unstructured":"Karaisli S, Haciyanli M, Gucek Haciyanli S, et al. Spindle epithelial tumour with thymus-like differentiation: report of two cases. Ann R Coll Surg Engl 2020; 102:e33-e35","journal-title":"Ann R Coll Surg Engl"},{"key":"9707_CR251","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/PAS.0b013e31819e61c8","volume":"33","author":"AL Folpe","year":"2009","unstructured":"Folpe AL, Lloyd RV, Bacchi CE, et al. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Am J Surg Pathol 2009; 33:1179-1186","journal-title":"Am J Surg Pathol"},{"key":"9707_CR252","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1365-2559.1998.00441.x","volume":"33","author":"R Chetty","year":"1998","unstructured":"Chetty R, Goetsch S, Nayler S, et al. Spindle epithelial tumour with thymus-like element (SETTLE): the predominantly monophasic variant. Histopathology 1998; 33:71-74","journal-title":"Histopathology"},{"key":"9707_CR253","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0046-8177(91)90083-2","volume":"22","author":"JK Chan","year":"1991","unstructured":"Chan JK, Rosai J. Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 1991; 22:349-367","journal-title":"Hum Pathol"},{"key":"9707_CR254","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1385\/EP:16:2:139","volume":"16","author":"AY Abrosimov","year":"2005","unstructured":"Abrosimov AY, LiVolsi VA. Spindle epithelial tumor with thymus-like differentiation (SETTLE) of the thyroid with neck lymph node metastasis: a case report. Endocr Pathol 2005; 16:139-143","journal-title":"Endocr Pathol"},{"key":"9707_CR255","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12105-018-0927-1","volume":"13","author":"TM Stevens","year":"2019","unstructured":"Stevens TM, Morlote D, Swensen J, et al. Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study. Head Neck Pathol 2019; 13:162-168","journal-title":"Head Neck Pathol"},{"key":"9707_CR256","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12020-015-0716-5","volume":"51","author":"S Ippolito","year":"2016","unstructured":"Ippolito S, Bellevicine C, Arpaia D, et al. Spindle epithelial tumor with thymus-like differentiation (SETTLE): clinical-pathological features, differential pathological diagnosis and therapy. Endocrine 2016; 51:402-412","journal-title":"Endocrine"},{"key":"9707_CR257","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/hed.23634","volume":"37","author":"G Recondo Jr","year":"2015","unstructured":"Recondo G, Jr., Busaidy N, Erasmus J, et al. Spindle epithelial tumor with thymus-like differentiation: A case report and comprehensive review of the literature and treatment options. Head Neck 2015; 37:746-754","journal-title":"Head Neck"},{"key":"9707_CR258","first-page":"42","volume":"43","author":"ZG Zheng","year":"2021","unstructured":"Zheng ZG, Sun WY. Clinicopathological Features of Intrathyroid Thymic Carcinoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2021; 43:42-46","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"9707_CR259","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1309\/VM7E52B6U9Q729DQ","volume":"127","author":"Y Ito","year":"2007","unstructured":"Ito Y, Miyauchi A, Nakamura Y, et al. Clinicopathologic significance of intrathyroidal epithelial thymoma\/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol 2007; 127:230-236","journal-title":"Am J Clin Pathol"},{"key":"9707_CR260","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1097\/00000478-200608000-00010","volume":"30","author":"JD Reimann","year":"2006","unstructured":"Reimann JD, Dorfman DM, Nose V. Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol 2006; 30:994-1001","journal-title":"Am J Surg Pathol"},{"key":"9707_CR261","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/BF01656263","volume":"9","author":"A Miyauchi","year":"1985","unstructured":"Miyauchi A, Kuma K, Matsuzuka F, et al. Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid. World J Surg 1985; 9:128-135","journal-title":"World J Surg"},{"key":"9707_CR262","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1530\/ERC-21-0123","volume":"28","author":"C Gurizzan","year":"2021","unstructured":"Gurizzan C, Zamparini M, Volante M, et al. Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis. Endocr Relat Cancer 2021; 28:593-604","journal-title":"Endocr Relat Cancer"},{"key":"9707_CR263","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12022-020-09635-0","volume":"31","author":"I Tahara","year":"2020","unstructured":"Tahara I, Oishi N, Mochizuki K, et al. Identification of Recurrent TERT Promoter Mutations in Intrathyroid Thymic Carcinomas. Endocr Pathol 2020; 31:274-282","journal-title":"Endocr Pathol"},{"key":"9707_CR264","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/gcc.20458","volume":"46","author":"Y Tirado","year":"2007","unstructured":"Tirado Y, Williams MD, Hanna EY, et al. CRTC1\/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin\u2019s tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 2007; 46:708-715","journal-title":"Genes Chromosomes Cancer"},{"key":"9707_CR265","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","volume":"32","author":"B Boyraz","year":"2021","unstructured":"Boyraz B, Sadow PM, Asa SL, et al. Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis. Endocr Pathol 2021; 32:327-335","journal-title":"Endocr Pathol"},{"key":"9707_CR266","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1089\/thy.2013.0589","volume":"24","author":"SM Giannelli","year":"2014","unstructured":"Giannelli SM, McPhaul L, Nakamoto J, et al. Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecular mechanisms. Thyroid 2014; 24:1184-1189","journal-title":"Thyroid"},{"key":"9707_CR267","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.humpath.2015.04.010","volume":"46","author":"MJ Kwon","year":"2015","unstructured":"Kwon MJ, Rho YS, Jeong JC, et al. Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation. Hum Pathol 2015; 46:1180-1188","journal-title":"Hum Pathol"},{"key":"9707_CR268","doi-asserted-by":"publisher","first-page":"803","DOI":"10.5858\/133.5.803","volume":"133","author":"D Schuetze","year":"2009","unstructured":"Schuetze D, Hoschar AP, Seethala RR, et al. The T1799A BRAF mutation is absent in cribriform-morular variant of papillary carcinoma. Arch Pathol Lab Med 2009; 133:803-805","journal-title":"Arch Pathol Lab Med"},{"key":"9707_CR269","doi-asserted-by":"crossref","unstructured":"Iftikhar H, Awan MS, Ghaloo SK, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid. BMJ Case Rep 2019; 12","DOI":"10.1136\/bcr-2018-225685"},{"key":"9707_CR270","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/modpathol.2016.180","volume":"30","author":"AA Shah","year":"2017","unstructured":"Shah AA, La Fortune K, Miller C, et al. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity. Mod Pathol 2017; 30:329-339","journal-title":"Mod Pathol"},{"key":"9707_CR271","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.humpath.2015.01.012","volume":"46","author":"G Quiroga-Garza","year":"2015","unstructured":"Quiroga-Garza G, Lee JH, El-Naggar A, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported. Hum Pathol 2015; 46:725-731","journal-title":"Hum Pathol"},{"key":"9707_CR272","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.anndiagpath.2003.09.002","volume":"7","author":"J Albores-Saavedra","year":"2003","unstructured":"Albores-Saavedra J, Gu X, Luna MA. Clear cells and thyroid transcription factor I reactivity in sclerosing mucoepidermoid carcinoma of the thyroid gland. Ann Diagn Pathol 2003; 7:348-353","journal-title":"Ann Diagn Pathol"},{"key":"9707_CR273","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1507\/endocrj.EJ17-0462","volume":"65","author":"M Hirokawa","year":"2018","unstructured":"Hirokawa M, Takada N, Abe H, et al. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia distinct from the salivary type. Endocr J 2018; 65:427-436","journal-title":"Endocr J"},{"key":"9707_CR274","doi-asserted-by":"crossref","unstructured":"Mao R, Shi L, Yan W, et al. Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eosinophilia: A case report. Medicine (Baltimore) 2020; 99:e22783","DOI":"10.1097\/MD.0000000000022783"},{"key":"9707_CR275","doi-asserted-by":"crossref","unstructured":"Agaimy A, Togel L, Stoehr R, et al. NSD3-NUTM1-rearranged carcinoma of the median neck\/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case. Virchows Arch 2021;","DOI":"10.1007\/s00428-021-03103-8"},{"key":"9707_CR276","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13256-019-2288-0","volume":"13","author":"JS Sukumar","year":"2019","unstructured":"Sukumar JS, Sukumar S, Purohit D, et al. Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two case reports and review of the literature. J Med Case Rep 2019; 13:385","journal-title":"J Med Case Rep"},{"key":"9707_CR277","doi-asserted-by":"crossref","unstructured":"Chan JK, Albores-Saavedra J, Battifora H, et al. Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto\u2019s thyroiditis. Am J Surg Pathol 1991; 15:438\u2013448","DOI":"10.1097\/00000478-199105000-00003"},{"key":"9707_CR278","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/modpathol.3800021","volume":"17","author":"JL Hunt","year":"2004","unstructured":"Hunt JL, LiVolsi VA, Barnes EL. p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid. Mod Pathol 2004; 17:526-529","journal-title":"Mod Pathol"},{"key":"9707_CR279","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1089\/thy.2017.0280","volume":"27","author":"JC Hernandez-Prera","year":"2017","unstructured":"Hernandez-Prera JC, Machado RA, Asa SL, et al. Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus? Thyroid 2017; 27:1498-1504","journal-title":"Thyroid"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09707-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-022-09707-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09707-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T20:45:25Z","timestamp":1700340325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-022-09707-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":279,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9707"],"URL":"https:\/\/doi.org\/10.1007\/s12022-022-09707-3","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"27 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Ozgur Mete is the Editor-in-Chief of <i>Endocrine Pathology<\/i>. This article was handled by an independent senior editor and peer-reviewed as per the journal standards. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}